Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.59 - $2.7 $24,804 - $42,120
-15,600 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$2.02 - $3.92 $91,708 - $177,968
-45,400 Reduced 74.43%
15,600 $37,000
Q4 2021

Feb 11, 2022

BUY
$3.74 - $6.7 $50,864 - $91,120
13,600 Added 28.69%
61,000 $228,000
Q3 2021

Nov 12, 2021

BUY
$6.05 - $10.41 $43,560 - $74,952
7,200 Added 17.91%
47,400 $286,000
Q2 2021

Aug 12, 2021

BUY
$6.66 - $10.92 $45,288 - $74,256
6,800 Added 20.36%
40,200 $381,000
Q1 2021

May 17, 2021

BUY
$4.59 - $18.74 $153,306 - $625,916
33,400 New
33,400 $295,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $176M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.